Catalyst Pharma Stock Price (NASDAQ:CPRX)

Add to My Stocks
$2.01 $0.31 (18.24%) CPRX stock closing price Mar 27, 2017 (Closing)
Prev Close* : $1.70
Market Cap:
Day Low: $1.63
52 Week Low: $0.51
Open: $1.72
Volume: 4485126
Day High: $2.07
52 Week High: $2.07

Latest Stock Market News

Latest Articles

Catalyst Pharma News - From Partners

CPRX Stockcharts

View CPRX PE ratio, PS ratio stocks charts and compare with peers.
CPRX Chart
Note: Compare Catalyst Pharma stock price history with the index and industry peers.

CPRX Industry Peers

Company Price Change (%)
Adamis Pharma (ADMP)4.250.05 (1.16%)
Cardiome Pharma (CRME)3.040 (0%)
Biomarin Pharma (BMRN)88.230.86 (0.98%)
Auspex Pharma (ASPX)100.960 (0%)
Acorda Therapeutics (ACOR)26.41 (3.94%)
Pfizer (PFE)34.180.18 (0.53%)
Abbott (ABT)44.70.03 (0.07%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Catalyst Pharma (CPRX)2.010.31 (18.24%)
Aralez Pharma (ARLZ)2.420.23 (10.5%)
Rigel Pharma (RIGL)3.430.3 (9.58%)
Flexion Therapeutics (FLXN)29.261.99 (7.3%)
Cempra (CEMP)4.350.25 (6.1%)
Endo International (ENDP)10.50.53 (5.32%)
Corcept Therapeutics (CORT)10.650.53 (5.24%)
Top gainers from Medical-Drugs industry
* As of Mar 28, 2017
CompanyPriceChange (%)
Redhill Biopharma (RDHL)10.230.24 (2.29%)
Tesaro Inc (TSRO)156.733.27 (2.04%)
Esperion Therapeutics (ESPR)38.270.67 (1.72%)
Ignyta (RXDX)9.150.1 (1.08%)
AcelRx Pharma (ACRX)3.050.03 (0.98%)
Xencor (XNCR)24.30.23 (0.94%)
La Jolla Pharma (LJPC)34.630.29 (0.83%)
Top losers from Medical-Drugs industry
* As of Mar 28, 2017

Catalyst Pharmaceuticals Inc Stock News - Partner Headlines

Catalyst Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues-----
Net Income-20.23M-15.5M-12.15M-4.07M-6.39M
Total Operating Expense20.39M14.58M10.3M5.21M6.07M
view Catalyst Pharmaceuticals Inc income statement
balance sheet20152014201320122011
Total Assets60.1M43.9M25.36M16.78M6.24M
Total Liabilities4.62M8.66M3.97M2.16M2.48M
Shareholders Equity55.47M35.24M21.39M14.62M3.76M
view Catalyst Pharmaceuticals Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities0.66M0.76M0.19M-0.28M0.62M
Net Cash From (Used By) Operating Activities-18.01M-12.94M-9.87M-5.14M-4.98M
Increase (Decrease) In Prop Plant And Equipment-0.02M-0.05M-0.01M-0.05M-
view Catalyst Pharmaceuticals Inc cashflow statement

Catalyst Pharma Stock Message Board

As of last trading day, Catalyst Pharma stock price was 2.01. Looking at Catalyst Pharma market capitalization, which currently stands at 141.05M, we can say that CPRX stock is a Micro cap stock. Catalyst Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Catalyst Pharma is worth a lot, it will most likely be reflected in an inflated Catalyst Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 4485126 shares were traded with a closing stock price of 2.01 as of 27 Mar, 2017, as can be seen from Catalyst Pharma stock quote. One can view Catalyst Pharma stock chart to follow the stock price trend. To check the historical stock price movement, all time high, and all time low of CPRX, view Catalyst Pharma stock price history.